Colorectal (Colon or Rectal) Cancer clinical trials at University of California Health

2 in progress, 1 open to eligible people

Showing trials for

  • Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer

    open to eligible people ages 18 years and up

    This study will investigate the safety, tolerability, pharmacokinetics, and anti-tumor activity of CBI-1214 in participants with advanced or metastatic Microsatellite Stable (MSS)/Microsatellite Instability Low (MSI-L) Colorectal Cancer

    at UCLA UCSF

  • BHB810 in Advanced Gastric and GEJ Adenocarcinoma

    Sorry, not currently recruiting here

    This study is looking at how safe BHB810 is in adults with gastric and gastroesophageal adenocarcinoma (GEJ). The purpose of this study is also to look at: how well the study drug works, how the study drug moves into, through, and out of the body, and how your body reacts to the study drug. Participants will get an IV infusion of BHB810 every 2 weeks while on study treatment.

    at UCLA

Our lead scientists for Colorectal (Colon or Rectal) Cancer research studies include .

Last updated: